AMY STUDER: Open Payments
NPI 1215443171 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 26 payments from 13 companies in 2025. Trend: 2023 $798 · 2024 $714 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $186 |
| Lilly USA, LLC | 6 | $165 |
| Inspire Medical Systems, Inc. | 2 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Organon LLC | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: INSPIRE, QULIPTA, ZEPBOUND, CAPLYTA, VRAYLAR, AIRSUPRA, MOUNJARO, BREZTRI.
Industry payments across TX — which companies pay providers there.
